Stempeutics receives European Process Patent for stem cell drug Stempeucel – Hindu Business Line
|
Stempeutics receives European Process Patent for stem cell drug Stempeucel
Hindu Business Line Stempeutics Research, an advanced clinical stage biotech company, today announced that the European Patent Office (EPO) has granted a process patent for its novel stem cell-based drug Stempeucel. “We have received European Process Patent for our … |
